2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Delusions: new trials by email Literature Review of Delusions trials Research Report on Delusions
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis Placebo, Pimavanserin 34 mg, Pimavanserin 20 mg - Dementia-related Psychosis | Phase 3 | Completed | ACADIA Pharmaceuticals Inc. | 392 | 2017-09-27 | 2021-06-21 |
| Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants Ethyl-eicosapentaenoic acid (EPA), Vitamins E + C, Etyl EPA (placebo) - Schizophrenia, Schizophreniform Disorders | Phase 2 / Phase 3 | Completed | University Hospital, Aker | 99 | 2001-09-01 | 2011-01-04 |
Hallucinations (2) · Psychotic Disorders (2) · Alzheimer Disease (1) · Corticobasal Degeneration (1) · Dementia (1) · Dementia, Vascular (1) · Hypertriglyceridemia (1) · Lewy Body Disease (1) · Schizophrenia (1) · Supranuclear Palsy, Progressive (1)
Behavior (2) · Behavioral Symptoms (2) · Mental Disorders (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Perceptual Disorders (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Cardiovascular Diseases (1)
eicosapentaenoic acid ethyl ester (1) · pimavanserin (1)
ACADIA Pharmaceuticals Inc. (1) · University Hospital, Aker (1)
Bulgaria (1) · Chile (1) · Czechia (1) · France (1) · Germany (1) · Italy (1) · Norway (1) · Poland (1) · Serbia (1) · Slovakia (1) · Spain (1) · Ukraine (1) · United Kingdom (1) · United States (1)
PMID 34289275, PMID 34934801, PMID 41286676
2017 (1)